Early Life and Education
Pablo Legorreta was born in 1963 or 1964. He holds a Bachelor of Science in Engineering from Universidad Iberoamericana in Mexico City.
Rise to Success
Legorreta began his career at Lazard Frères, where he worked in investment banking, specializing in mergers and acquisitions in Paris and New York. In 1996, he founded Royalty Pharma, a company that has become the world's largest acquirer of pharmaceutical royalty streams. Royalty Pharma invests in intellectual property, primarily in the form of royalties in pharmaceutical and biotechnology products. The firm funds innovation in the life sciences by acquiring existing royalty interests from academic institutions, research hospitals, foundations, and inventors. The company's IPO in 2020 was a significant milestone, valuing Royalty Pharma at $16.7 billion and highlighting Legorreta's success.
Key Business Strategies
Royalty Pharma's business model involves acquiring royalty streams from successful pharmaceutical products. This strategy has allowed the company to generate substantial revenue from drugs such as Humira, Imbruvica, and Lyrica. Legorreta has also expanded the company's focus to include funding research and development, making it a direct source of capital for innovation in the biopharmaceutical industry.
Philanthropy
Legorreta is committed to philanthropy, particularly in healthcare. He founded Alianza Médica para la Salud (AMSA), which provides scholarships to Latin American doctors to improve healthcare quality in the region. Additionally, he and his wife, Almudena, have made a $25 million gift to Brown University to accelerate cancer research and rename the cancer center the Legorreta Cancer Center.
